Home›Stock Screener›Accretion Nutraveda›Financial Statements

Accretion Nutraveda Complete Financial Statements

4 Years of Data
2026 - 2023

In FYNone, Accretion Nutraveda (ANL) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 14.7% and ROE of 13.9%. Full financial statements from FY2023 to FY2026 (4 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Accretion Nutraveda share price chart.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 14.71% 2026 data
EBITDA Margin 20.59% 2026 data
Operating Margin 21.00% 2026 data
Return on Assets 11.90% 2026 data
Return on Equity 13.89% 2026 data

Balance Sheet Ratios

Current Ratio 7.50 2026 data
Equity Ratio 85.71% 2026 data
Asset Turnover 0.81 2026 data

ANL Revenue, Net Profit & EBITDA — Year-on-Year Growth

ANL YoY (March 2026 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. Analyse ANL institutional holdings to track promoter, FII and institutional holdings.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+281.8%
Year-over-Year
Equity Growth
+620.0%
Year-over-Year
Operating Cash Flow Growth
-350.0%
Year-over-Year
Investing Cash Flow Growth
-1400.0%
Year-over-Year
Financing Cash Flow Growth
+733.3%
Year-over-Year

ANL Income Statement — Revenue, EBITDA & Net Profit

Accretion Nutraveda revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 14.7%. Also explore ANL price trends to track price trends across different timeframes.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023
Revenue 0 34 16 5 3
Expenses 0 27 12 4 2
EBITDA 0 7 4 1 1
Operating Profit Margin % 0.00% 21.00% 23.00% 24.00% 21.00%
Depreciation 0 0 0 0 0
Interest 0 1 0 0 0
Profit Before Tax 0 6 3 1 0
Tax 0 1 1 0 0
Net Profit 0 5 3 1 0
Earnings Per Share (₹) 0.00 9.35 6.88 22.83 7.79

ANL Balance Sheet — Assets, Liabilities & Shareholders' Equity

ANL total assets ₹42 Cr, total equity ₹36 Cr, total liabilities ₹ Cr (2026) — ROE 13.9%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023
ASSETS
Total Assets 42 11 5 4
Current Assets 30 9 3 3
Fixed Assets 2 2 1 2
Capital Work in Progress 0 0 0 0
Investments 0 0 0 0
Other Assets 40 9 3 3
LIABILITIES
Total Liabilities
Current Liabilities 4 3 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 36 5 1 0
Share Capital 7 1 0 0
Reserves & Surplus 28 5 1 0

ANL Cash Flow Statement — Operating, Investing & Financing

Accretion Nutraveda operating cash flow ₹-9 Cr, investing ₹-15 Cr, financing ₹25 Cr, net cash flow ₹1 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023
Operating Activities -9 -2 0 1
Investing Activities -15 -1 0 0
Financing Activities 25 3 0 -1
Net Cash Flow 1 0 0 0